{"id":"https://openalex.org/W2159023488","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2235","title":"Effects of Smoking on the Pharmacokinetics of Erlotinib","display_name":"Effects of Smoking on the Pharmacokinetics of Erlotinib","alternate_titles":[],"publication_year":2006,"publication_date":"2006-04-01","ids":{"openalex":"https://openalex.org/W2159023488","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2235","mag":"2159023488","pmid":"https://pubmed.ncbi.nlm.nih.gov/16609030"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-05-2235","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2235","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-05-2235","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2159023488"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000921919","display_name":"Marta Hamilton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marta Hamilton","raw_affiliation_strings":["Authors' Affiliation: OSI Pharmaceuticals, Inc., Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: OSI Pharmaceuticals, Inc., Boulder, Colorado","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111976558","display_name":"Julie L. Wolf","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julie L. Wolf","raw_affiliation_strings":["Authors' Affiliation: OSI Pharmaceuticals, Inc., Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: OSI Pharmaceuticals, Inc., Boulder, Colorado","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018437041","display_name":"Jason Rusk","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason Rusk","raw_affiliation_strings":["Authors' Affiliation: OSI Pharmaceuticals, Inc., Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: OSI Pharmaceuticals, Inc., Boulder, Colorado","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025198650","display_name":"Shannon E. Beard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shannon E. Beard","raw_affiliation_strings":["Authors' Affiliation: OSI Pharmaceuticals, Inc., Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: OSI Pharmaceuticals, Inc., Boulder, Colorado","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Gary M. Clark","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary M. Clark","raw_affiliation_strings":["Authors' Affiliation: OSI Pharmaceuticals, Inc., Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: OSI Pharmaceuticals, Inc., Boulder, Colorado","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Karsten Witt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karsten Witt","raw_affiliation_strings":["Authors' Affiliation: OSI Pharmaceuticals, Inc., Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: OSI Pharmaceuticals, Inc., Boulder, Colorado","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111612394","display_name":"Pablo J. Cagnoni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pablo J. Cagnoni","raw_affiliation_strings":["Authors' Affiliation: OSI Pharmaceuticals, Inc., Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: OSI Pharmaceuticals, Inc., Boulder, Colorado","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":10.6785,"has_fulltext":false,"cited_by_count":328,"citation_normalized_percentile":{"value":0.99271318,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"12","issue":"7","first_page":"2166","last_page":"2171"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8622999787330627,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8622999787330627,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.08169999718666077,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10060","display_name":"Smoking Behavior and Cessation","score":0.03590000048279762,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.9950000047683716},{"id":"https://openalex.org/keywords/smoking","display_name":"smoking","score":0.9760000109672546},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9950000047683716},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.5149999856948853},{"id":"https://openalex.org/keywords/metabolic-clearance","display_name":"metabolic clearance","score":0.8939999938011169},{"id":"https://openalex.org/keywords/smokers-versus-nonsmokers","display_name":"smokers versus non-smokers","score":0.796999990940094},{"id":"https://openalex.org/keywords/auc","display_name":"AUC","score":0.5740000009536743},{"id":"https://openalex.org/keywords/cmax","display_name":"Cmax","score":0.6299999952316284},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.40299999713897705}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.9135885834693909},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.9081441760063171},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8058140277862549},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.47127315402030945},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45272377133369446},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3614048361778259},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34948158264160156},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.13520947098731995},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.056103289127349854}],"mesh":[{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012449","descriptor_name":"Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012907","descriptor_name":"Smoking","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-05-2235","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2235","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-05-2235","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:16609030","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16609030","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W60886506","https://openalex.org/W167846478","https://openalex.org/W179281078","https://openalex.org/W1448125543","https://openalex.org/W1779286308","https://openalex.org/W1964646109","https://openalex.org/W1984409435","https://openalex.org/W1985597417","https://openalex.org/W1992656252","https://openalex.org/W1996151392","https://openalex.org/W2004661032","https://openalex.org/W2009906225","https://openalex.org/W2028850868","https://openalex.org/W2036228589","https://openalex.org/W2052536634","https://openalex.org/W2061159049","https://openalex.org/W2065451737","https://openalex.org/W2138297714","https://openalex.org/W2152782390","https://openalex.org/W2163607253","https://openalex.org/W2240490034","https://openalex.org/W2274356777","https://openalex.org/W2278057905","https://openalex.org/W2415082840","https://openalex.org/W2591571563","https://openalex.org/W3024199366","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2140617449","https://openalex.org/W2242986312","https://openalex.org/W2012875002","https://openalex.org/W2243595844","https://openalex.org/W2045291815","https://openalex.org/W2080669049","https://openalex.org/W2463976785","https://openalex.org/W3039417008","https://openalex.org/W4406787097","https://openalex.org/W2601533838"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"compare":[2],"the":[3,89,93,113,142,150,155,167,175,184],"pharmacokinetic":[4,32,54],"variables":[5],"of":[6,23,110,122,139,152,186,223],"erlotinib":[7,57,76,96,187,224],"in":[8,34,98,104,118,124,128,134,164,172,190,204,213,225],"current":[9,191,226],"smokers":[10,50,72,99,119,129,140,153,165,192,205],"with":[11,207,219],"nonsmokers":[12,105,111,173],"after":[13],"receiving":[14],"a":[15,29,79,210],"single":[16,80],"oral":[17],"150":[18,81,90,156,176],"or":[19,82],"300":[20,83,114,143,168],"mg":[21,84,91,115,144,157,169,177],"dose":[22,85,145,170],"erlotinib.":[24],"EXPERIMENTAL":[25],"DESIGN:":[26],"This":[27,180],"was":[28,62,100,120,130,146,162,215],"single-center,":[30],"open-label":[31],"study":[33,181],"healthy":[35],"male":[36],"subjects.":[37],"Subjects":[38],"were":[39,201],"enrolled":[40],"into":[41],"two":[42],"treatment":[43],"cohorts":[44],"based":[45],"on":[46],"smoking":[47],"status":[48],"(current":[49],"and":[51,58,106,126,193,199,209],"nonsmokers).":[52],"The":[53,136,159,195],"profile":[55],"for":[56,64],"its":[59],"metabolite,":[60],"OSI-420,":[61],"determined":[63],"each":[65,68],"subject":[66],"following":[67,78],"treatment.":[69],"RESULTS:":[70],"Current":[71],"achieved":[73],"significantly":[74,202],"less":[75,148],"exposure":[77],"than":[86,103,133,149,171],"nonsmokers.":[87,135,194],"Following":[88],"dose,":[92],"geometric":[94],"mean":[95],"AUC(0-infinity)":[97,198],"2.8-fold":[101],"lower":[102,132],"similar":[107],"to":[108],"that":[109,123,183,197],"at":[112,141,154,166,174],"dose.":[116,158,178],"C(max)":[117,161,214],"two-thirds":[121],"nonsmokers,":[125,208],"C(24h)":[127,138,151,200],"8.3-fold":[131],"median":[137,160],"slightly":[147],"greater":[163],"CONCLUSION:":[179],"confirms":[182],"pharmacokinetics":[185],"is":[188,217],"different":[189],"observation":[196],"decreased":[203],"compared":[206],"smaller":[211],"decrease":[212],"observed,":[216],"consistent":[218],"increased":[220],"metabolic":[221],"clearance":[222],"smokers.":[227]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2159023488","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":15},{"year":2019,"cited_by_count":17},{"year":2018,"cited_by_count":18},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":17},{"year":2015,"cited_by_count":24},{"year":2014,"cited_by_count":24},{"year":2013,"cited_by_count":29},{"year":2012,"cited_by_count":19}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2016-06-24T00:00:00"}
